Roche (OTCMKTS:RHHBY) Lowered to “Moderate Sell” Rating by Jefferies Financial Group

Roche (OTCMKTS:RHHBY) was downgraded by equities research analysts at Jefferies Financial Group from a “hold” rating to a “moderate sell” rating in a note issued to investors on Monday,Zacks.com reports.

RHHBY has been the topic of a number of other research reports. HSBC upgraded Roche from a “hold” rating to a “buy” rating and set a $50.00 price objective on the stock in a research report on Thursday, October 2nd. Hsbc Global Res upgraded Roche from a “hold” rating to a “strong-buy” rating in a report on Thursday, October 2nd. Three investment analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, Roche presently has a consensus rating of “Buy” and a consensus price target of $50.00.

Roche Stock Performance

OTCMKTS:RHHBY opened at $42.09 on Monday. The company has a fifty day moving average of $42.46 and a two-hundred day moving average of $40.73. Roche has a fifty-two week low of $34.10 and a fifty-two week high of $45.94.

Institutional Investors Weigh In On Roche

Large investors have recently modified their holdings of the stock. Boston Common Asset Management LLC raised its position in Roche by 11.1% during the 2nd quarter. Boston Common Asset Management LLC now owns 361,833 shares of the company’s stock worth $14,682,000 after buying an additional 36,101 shares during the last quarter. OLD National Bancorp IN increased its stake in shares of Roche by 2.9% during the second quarter. OLD National Bancorp IN now owns 261,317 shares of the company’s stock worth $10,604,000 after acquiring an additional 7,326 shares during the period. Bard Financial Services Inc. increased its stake in shares of Roche by 1.3% during the third quarter. Bard Financial Services Inc. now owns 138,650 shares of the company’s stock worth $5,797,000 after acquiring an additional 1,800 shares during the period. Rhumbline Advisers raised its holdings in Roche by 1.1% during the second quarter. Rhumbline Advisers now owns 108,480 shares of the company’s stock worth $4,422,000 after purchasing an additional 1,228 shares in the last quarter. Finally, Yousif Capital Management LLC lifted its position in Roche by 7.8% in the second quarter. Yousif Capital Management LLC now owns 88,547 shares of the company’s stock valued at $3,593,000 after purchasing an additional 6,395 shares during the period.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.